雾化芬太尼治疗慢性阻塞性肺疾病（COPD）继发的难治性呼吸困难：一例报告
Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report.
作者信息
Hildreth Leah, Pett Danielle, Higgins Elizabeth
机构信息
Medical University of South Carolina, 171 Ashley Ave, Charleston, SC, 29425, USA.
出版信息
Respir Med Case Rep. 2020 Oct 12;31:101251. doi: 10.1016/j.rmcr.2020.101251. eCollection 2020.
Abstract
We present a case where we evaluated the effectiveness of nebulized fentanyl in the treatment of refractive dyspnea in a patient with chronic obstructive pulmonary disease (COPD) with major complications and comorbidities. Nebulized fentanyl was used to successfully decrease the subjective symptoms of refractory dyspnea in this given patient. Nebulized fentanyl appears to be a cost-effective treatment option in patients that experience episodes of severe shortness of breath (SOB).
摘要
我们报告了一例对患有严重并发症和合并症的慢性阻塞性肺疾病（COPD）患者雾化使用芬太尼治疗难治性呼吸困难有效性的评估病例。雾化使用芬太尼成功减轻了该特定患者难治性呼吸困难的主观症状。对于经历严重呼吸急促发作的患者，雾化芬太尼似乎是一种具有成本效益的治疗选择。
相似文献
1
Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report.雾化芬太尼治疗慢性阻塞性肺疾病（COPD）继发的难治性呼吸困难：一例报告
Respir Med Case Rep. 2020 Oct 12;31:101251. doi: 10.1016/j.rmcr.2020.101251. eCollection 2020.
2
Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.枸橼酸芬太尼雾化吸入改善慢性阻塞性肺疾病患者高负荷等长运动耐力。
J Pain Symptom Manage. 2012 Apr;43(4):706-19. doi: 10.1016/j.jpainsymman.2011.05.007. Epub 2011 Dec 14.
3
Inhaled nebulized and intranasal opioids for the relief of breathlessness.吸入雾化和鼻内使用阿片类药物以缓解呼吸困难。
Curr Opin Support Palliat Care. 2014 Sep;8(3):208-12. doi: 10.1097/SPC.0000000000000071.
4
Nebulized medications for the treatment of dyspnea: a literature review.用于治疗呼吸困难的雾化药物：文献综述
J Aerosol Med Pulm Drug Deliv. 2015 Feb;28(1):1-19. doi: 10.1089/jamp.2014.1136. Epub 2014 Jun 10.
5
Does nebulized fentanyl relieve dyspnea during exercise in healthy man?雾化芬太尼能否缓解健康男性运动期间的呼吸困难？
J Appl Physiol (1985). 2015 Jun 1;118(11):1406-14. doi: 10.1152/japplphysiol.01091.2014. Epub 2015 Mar 12.
6
Factor analysis of laboratory and clinical measurements of dyspnea in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者呼吸困难的实验室及临床测量指标的因子分析
J Pain Symptom Manage. 2003 Feb;25(2):118-27. doi: 10.1016/s0885-3924(02)00690-5.
7
Nebulized opioids for the palliation of dyspnea in terminally ill patients.雾化吸入阿片类药物用于缓解晚期患者的呼吸困难。
Am J Health Syst Pharm. 2017 Jul 15;74(14):1053-1061. doi: 10.2146/ajhp150893.
8
Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators.慢性阻塞性肺疾病 Medicare 受益人群的住院再入院率降低：雾化支气管扩张剂的真实世界结局研究。
Clin Ther. 2019 Nov;41(11):2283-2296. doi: 10.1016/j.clinthera.2019.09.001. Epub 2019 Oct 17.
9
Nebulized Fentanyl for Dyspnea in a Hospice Patient with True Allergy to Morphine and Hydromorphone.
J Pain Palliat Care Pharmacother. 2017 Mar;31(1):38-42. doi: 10.1080/15360288.2017.1279499. Epub 2017 Feb 22.
10
Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.慢性阻塞性肺疾病患者使用雾化吸入阿福特罗：一项为期12周的多中心、随机、双盲、双模拟、安慰剂对照和活性药物对照试验。
Clin Ther. 2007 Feb;29(2):261-78. doi: 10.1016/j.clinthera.2007.02.009.
引用本文的文献
1
Combined analysis of bulk RNA and single-cell RNA sequencing to identify pyroptosis-related markers and the role of dendritic cells in chronic obstructive pulmonary disease.联合分析 bulk RNA 和单细胞 RNA 测序以鉴定焦亡相关标志物及树突状细胞在慢性阻塞性肺疾病中的作用。
Heliyon. 2024 Mar 8;10(6):e27808. doi: 10.1016/j.heliyon.2024.e27808. eCollection 2024 Mar 30.
本文引用的文献
1
Nebulized opioids for the palliation of dyspnea in terminally ill patients.雾化吸入阿片类药物用于缓解晚期患者的呼吸困难。
Am J Health Syst Pharm. 2017 Jul 15;74(14):1053-1061. doi: 10.2146/ajhp150893.
2
Treatment of Acute Dyspnea with Morphine to Avert Respiratory Failure.用吗啡治疗急性呼吸困难以避免呼吸衰竭。
Ann Am Thorac Soc. 2017 Apr;14(4):584-588. doi: 10.1513/AnnalsATS.201611-922CC.
3
Opioid receptor bronchial tree: current science.阿片受体与支气管树：当前科学进展
Curr Opin Support Palliat Care. 2014 Sep;8(3):191-9. doi: 10.1097/SPC.0000000000000072.
4
Nebulized medications for the treatment of dyspnea: a literature review.用于治疗呼吸困难的雾化药物：文献综述
J Aerosol Med Pulm Drug Deliv. 2015 Feb;28(1):1-19. doi: 10.1089/jamp.2014.1136. Epub 2014 Jun 10.
5
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.1990年和2010年20个年龄组中235种死因的全球和区域死亡率：全球疾病负担研究2010的系统分析
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
6
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.美国胸科学会官方声明：呼吸困难机制、评估和管理的更新。
Am J Respir Crit Care Med. 2012 Feb 15;185(4):435-52. doi: 10.1164/rccm.201111-2042ST.
7
Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease.晚期慢性阻塞性肺疾病患者的症状困扰与生活质量
J Pain Symptom Manage. 2009 Jul;38(1):115-23. doi: 10.1016/j.jpainsymman.2008.07.006. Epub 2009 Feb 20.
8
Opioid complications and side effects.阿片类药物的并发症及副作用。
Pain Physician. 2008 Mar;11(2 Suppl):S105-20.
9
Palliative management of refractory dyspnea in COPD.慢性阻塞性肺疾病难治性呼吸困难的姑息治疗
Int J Chron Obstruct Pulmon Dis. 2006;1(3):289-304. doi: 10.2147/copd.2006.1.3.289.
10
The use of nebulized fentanyl for the management of dyspnea.雾化芬太尼用于呼吸困难的管理。
Clin J Oncol Nurs. 2003 May-Jun;7(3):334-5. doi: 10.1188/03.CJON.334-336.
Zotero 插件